Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. RGEDF Peers
See (RGEDF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RGEDF | $27.17 | N/A | 5B | 7.99 | $3.40 | +4.99% |
| CLCGY | $42.99 | +0.44% | 20.4B | 30.71 | $1.40 | +0.09% |
| ALBHF | $0.67 | N/A | 10.7B | 66.60 | $0.01 | N/A |
| ALBBY | $11.09 | N/A | 8.9B | 44.36 | $0.25 | N/A |
| MSMKF | $18.11 | N/A | 7.3B | 19.47 | $0.93 | +1.66% |
| DCHPF | $46.90 | -0.21% | 5.3B | -151.29 | -$0.31 | N/A |
| RADLY | $3.01 | +20.88% | 5.2B | 25.08 | $0.12 | +0.37% |
| GEDSF | $24.85 | N/A | 4.5B | 10.71 | $2.32 | +5.76% |
| CSMYF | $46.06 | N/A | 3.7B | 19.77 | $2.33 | +0.47% |
| WLCGF | $16.41 | N/A | 3.4B | 19.54 | $0.84 | +0.75% |
Stock Comparison
RGEDF vs CLCGY Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, CLCGY has a market cap of 20.4B. Regarding current trading prices, RGEDF is priced at $27.17, while CLCGY trades at $42.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas CLCGY's P/E ratio is 30.71. In terms of profitability, RGEDF's ROE is +0.20%, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, RGEDF is more volatile compared to CLCGY. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs ALBHF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, ALBHF has a market cap of 10.7B. Regarding current trading prices, RGEDF is priced at $27.17, while ALBHF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas ALBHF's P/E ratio is 66.60. In terms of profitability, RGEDF's ROE is +0.20%, compared to ALBHF's ROE of +0.06%. Regarding short-term risk, RGEDF is less volatile compared to ALBHF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs ALBBY Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, ALBBY has a market cap of 8.9B. Regarding current trading prices, RGEDF is priced at $27.17, while ALBBY trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas ALBBY's P/E ratio is 44.36. In terms of profitability, RGEDF's ROE is +0.20%, compared to ALBBY's ROE of +0.06%. Regarding short-term risk, RGEDF is more volatile compared to ALBBY. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs MSMKF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, MSMKF has a market cap of 7.3B. Regarding current trading prices, RGEDF is priced at $27.17, while MSMKF trades at $18.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas MSMKF's P/E ratio is 19.47. In terms of profitability, RGEDF's ROE is +0.20%, compared to MSMKF's ROE of +0.07%. Regarding short-term risk, RGEDF is less volatile compared to MSMKF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs DCHPF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, DCHPF has a market cap of 5.3B. Regarding current trading prices, RGEDF is priced at $27.17, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, RGEDF's ROE is +0.20%, compared to DCHPF's ROE of N/A. Regarding short-term risk, RGEDF is more volatile compared to DCHPF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs RADLY Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, RADLY has a market cap of 5.2B. Regarding current trading prices, RGEDF is priced at $27.17, while RADLY trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas RADLY's P/E ratio is 25.08. In terms of profitability, RGEDF's ROE is +0.20%, compared to RADLY's ROE of +0.18%. Regarding short-term risk, RGEDF is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs GEDSF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, GEDSF has a market cap of 4.5B. Regarding current trading prices, RGEDF is priced at $27.17, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, RGEDF's ROE is +0.20%, compared to GEDSF's ROE of +0.15%. Regarding short-term risk, RGEDF is more volatile compared to GEDSF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs CSMYF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, CSMYF has a market cap of 3.7B. Regarding current trading prices, RGEDF is priced at $27.17, while CSMYF trades at $46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas CSMYF's P/E ratio is 19.77. In terms of profitability, RGEDF's ROE is +0.20%, compared to CSMYF's ROE of +0.08%. Regarding short-term risk, RGEDF is more volatile compared to CSMYF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs WLCGF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, WLCGF has a market cap of 3.4B. Regarding current trading prices, RGEDF is priced at $27.17, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, RGEDF's ROE is +0.20%, compared to WLCGF's ROE of +0.07%. Regarding short-term risk, RGEDF is more volatile compared to WLCGF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SDGCF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SDGCF has a market cap of 3.3B. Regarding current trading prices, RGEDF is priced at $27.17, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, RGEDF's ROE is +0.20%, compared to SDGCF's ROE of +0.05%. Regarding short-term risk, RGEDF is more volatile compared to SDGCF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SHPPF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SHPPF has a market cap of 3B. Regarding current trading prices, RGEDF is priced at $27.17, while SHPPF trades at $148.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SHPPF's P/E ratio is -54.09. In terms of profitability, RGEDF's ROE is +0.20%, compared to SHPPF's ROE of -0.09%. Regarding short-term risk, RGEDF is less volatile compared to SHPPF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SGIPF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SGIPF has a market cap of 2.9B. Regarding current trading prices, RGEDF is priced at $27.17, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, RGEDF's ROE is +0.20%, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, RGEDF is more volatile compared to SGIPF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs TSUSF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, TSUSF has a market cap of 2.7B. Regarding current trading prices, RGEDF is priced at $27.17, while TSUSF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas TSUSF's P/E ratio is 16.87. In terms of profitability, RGEDF's ROE is +0.20%, compared to TSUSF's ROE of +0.06%. Regarding short-term risk, RGEDF is less volatile compared to TSUSF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SAEYY Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SAEYY has a market cap of 2.5B. Regarding current trading prices, RGEDF is priced at $27.17, while SAEYY trades at $12.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SAEYY's P/E ratio is -45.56. In terms of profitability, RGEDF's ROE is +0.20%, compared to SAEYY's ROE of -0.09%. Regarding short-term risk, RGEDF is more volatile compared to SAEYY. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs HTSUY Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, HTSUY has a market cap of 2.2B. Regarding current trading prices, RGEDF is priced at $27.17, while HTSUY trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas HTSUY's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to HTSUY's ROE of +0.08%. Regarding short-term risk, RGEDF is less volatile compared to HTSUY. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs BJTRF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, BJTRF has a market cap of 542.8M. Regarding current trading prices, RGEDF is priced at $27.17, while BJTRF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas BJTRF's P/E ratio is 8.10. In terms of profitability, RGEDF's ROE is +0.20%, compared to BJTRF's ROE of +0.03%. Regarding short-term risk, RGEDF is more volatile compared to BJTRF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs ZRSEF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, ZRSEF has a market cap of 411.7M. Regarding current trading prices, RGEDF is priced at $27.17, while ZRSEF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas ZRSEF's P/E ratio is -2.14. In terms of profitability, RGEDF's ROE is +0.20%, compared to ZRSEF's ROE of -0.26%. Regarding short-term risk, RGEDF is less volatile compared to ZRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs NVACF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, NVACF has a market cap of 78.5M. Regarding current trading prices, RGEDF is priced at $27.17, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas NVACF's P/E ratio is 31.60. In terms of profitability, RGEDF's ROE is +0.20%, compared to NVACF's ROE of +0.02%. Regarding short-term risk, RGEDF is more volatile compared to NVACF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs KIARF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, KIARF has a market cap of 67.4M. Regarding current trading prices, RGEDF is priced at $27.17, while KIARF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas KIARF's P/E ratio is -0.01. In terms of profitability, RGEDF's ROE is +0.20%, compared to KIARF's ROE of -1.47%. Regarding short-term risk, RGEDF is more volatile compared to KIARF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs HTPRF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, HTPRF has a market cap of 12.1M. Regarding current trading prices, RGEDF is priced at $27.17, while HTPRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas HTPRF's P/E ratio is -0.06. In terms of profitability, RGEDF's ROE is +0.20%, compared to HTPRF's ROE of +0.11%. Regarding short-term risk, RGEDF is more volatile compared to HTPRF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs ETBI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, ETBI has a market cap of 9M. Regarding current trading prices, RGEDF is priced at $27.17, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas ETBI's P/E ratio is -0.40. In terms of profitability, RGEDF's ROE is +0.20%, compared to ETBI's ROE of +0.00%. Regarding short-term risk, RGEDF is more volatile compared to ETBI. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs PNPL Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, PNPL has a market cap of 7.3M. Regarding current trading prices, RGEDF is priced at $27.17, while PNPL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas PNPL's P/E ratio is -10.00. In terms of profitability, RGEDF's ROE is +0.20%, compared to PNPL's ROE of +0.54%. Regarding short-term risk, RGEDF is more volatile compared to PNPL. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs FFLWF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, FFLWF has a market cap of 5.4M. Regarding current trading prices, RGEDF is priced at $27.17, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, RGEDF's ROE is +0.20%, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, RGEDF is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs RLLVF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, RLLVF has a market cap of 5.3M. Regarding current trading prices, RGEDF is priced at $27.17, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, RGEDF's ROE is +0.20%, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, RGEDF is more volatile compared to RLLVF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs HEWA Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, HEWA has a market cap of 3.8M. Regarding current trading prices, RGEDF is priced at $27.17, while HEWA trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas HEWA's P/E ratio is -2.94. In terms of profitability, RGEDF's ROE is +0.20%, compared to HEWA's ROE of +0.08%. Regarding short-term risk, RGEDF is less volatile compared to HEWA. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs LGNZZ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, LGNZZ has a market cap of 2.7M. Regarding current trading prices, RGEDF is priced at $27.17, while LGNZZ trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to LGNZZ's ROE of -0.16%. Regarding short-term risk, RGEDF is more volatile compared to LGNZZ. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs GABLF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, GABLF has a market cap of 2.7M. Regarding current trading prices, RGEDF is priced at $27.17, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas GABLF's P/E ratio is -0.04. In terms of profitability, RGEDF's ROE is +0.20%, compared to GABLF's ROE of +2.91%. Regarding short-term risk, RGEDF is more volatile compared to GABLF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SYDRF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SYDRF has a market cap of 2.3M. Regarding current trading prices, RGEDF is priced at $27.17, while SYDRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SYDRF's P/E ratio is 8.00. In terms of profitability, RGEDF's ROE is +0.20%, compared to SYDRF's ROE of +0.96%. Regarding short-term risk, RGEDF is less volatile compared to SYDRF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs CAFS Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, CAFS has a market cap of 2M. Regarding current trading prices, RGEDF is priced at $27.17, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas CAFS's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to CAFS's ROE of +1.94%. Regarding short-term risk, RGEDF is more volatile compared to CAFS. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs IWINF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, IWINF has a market cap of 1.7M. Regarding current trading prices, RGEDF is priced at $27.17, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas IWINF's P/E ratio is -0.06. In terms of profitability, RGEDF's ROE is +0.20%, compared to IWINF's ROE of -0.21%. Regarding short-term risk, RGEDF is more volatile compared to IWINF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs NUTTQ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, NUTTQ has a market cap of 1.1M. Regarding current trading prices, RGEDF is priced at $27.17, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, RGEDF is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs CNBI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, CNBI has a market cap of 686.8K. Regarding current trading prices, RGEDF is priced at $27.17, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas CNBI's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to CNBI's ROE of +0.17%. Regarding short-term risk, RGEDF is less volatile compared to CNBI. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs LGNYZ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, LGNYZ has a market cap of 675.3K. Regarding current trading prices, RGEDF is priced at $27.17, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to LGNYZ's ROE of -0.16%. Regarding short-term risk, RGEDF is more volatile compared to LGNYZ. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs RADCQ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, RADCQ has a market cap of 559.7K. Regarding current trading prices, RGEDF is priced at $27.17, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, RGEDF's ROE is +0.20%, compared to RADCQ's ROE of +3.01%. Regarding short-term risk, RGEDF is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs AEGY Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, AEGY has a market cap of 411.2K. Regarding current trading prices, RGEDF is priced at $27.17, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas AEGY's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to AEGY's ROE of +0.00%. Regarding short-term risk, RGEDF is less volatile compared to AEGY. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs IPAH Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, IPAH has a market cap of 273.6K. Regarding current trading prices, RGEDF is priced at $27.17, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas IPAH's P/E ratio is -0.05. In terms of profitability, RGEDF's ROE is +0.20%, compared to IPAH's ROE of -0.82%. Regarding short-term risk, RGEDF is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs FOGCF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, FOGCF has a market cap of 97.2K. Regarding current trading prices, RGEDF is priced at $27.17, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas FOGCF's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, RGEDF is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs MDIN Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, MDIN has a market cap of 90.3K. Regarding current trading prices, RGEDF is priced at $27.17, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas MDIN's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to MDIN's ROE of +0.36%. Regarding short-term risk, RGEDF is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs OXIHF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, OXIHF has a market cap of 65.7K. Regarding current trading prices, RGEDF is priced at $27.17, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas OXIHF's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, RGEDF is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs HADV Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, HADV has a market cap of 64.4K. Regarding current trading prices, RGEDF is priced at $27.17, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas HADV's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to HADV's ROE of +0.83%. Regarding short-term risk, RGEDF is less volatile compared to HADV. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs IMMB Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, IMMB has a market cap of 57.5K. Regarding current trading prices, RGEDF is priced at $27.17, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas IMMB's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to IMMB's ROE of -0.09%. Regarding short-term risk, RGEDF is more volatile compared to IMMB. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs RBII Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, RBII has a market cap of 49.9K. Regarding current trading prices, RGEDF is priced at $27.17, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas RBII's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to RBII's ROE of -0.04%. Regarding short-term risk, RGEDF is less volatile compared to RBII. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs LGNDZ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, LGNDZ has a market cap of 38.6K. Regarding current trading prices, RGEDF is priced at $27.17, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to LGNDZ's ROE of -0.16%. Regarding short-term risk, RGEDF is more volatile compared to LGNDZ. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs DECN Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, DECN has a market cap of 35.5K. Regarding current trading prices, RGEDF is priced at $27.17, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas DECN's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to DECN's ROE of +0.00%. Regarding short-term risk, RGEDF is more volatile compared to DECN. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SPPH Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SPPH has a market cap of 29.4K. Regarding current trading prices, RGEDF is priced at $27.17, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SPPH's P/E ratio is -0.03. In terms of profitability, RGEDF's ROE is +0.20%, compared to SPPH's ROE of -0.50%. Regarding short-term risk, RGEDF is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs LGNXZ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, LGNXZ has a market cap of 25.1K. Regarding current trading prices, RGEDF is priced at $27.17, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to LGNXZ's ROE of -0.16%. Regarding short-term risk, RGEDF is less volatile compared to LGNXZ. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs WPHM Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, WPHM has a market cap of 23.2K. Regarding current trading prices, RGEDF is priced at $27.17, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas WPHM's P/E ratio is -0.01. In terms of profitability, RGEDF's ROE is +0.20%, compared to WPHM's ROE of -1.56%. Regarding short-term risk, RGEDF is less volatile compared to WPHM. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SCRCQ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SCRCQ has a market cap of 14.1K. Regarding current trading prices, RGEDF is priced at $27.17, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, RGEDF's ROE is +0.20%, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, RGEDF is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs TSTS Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, TSTS has a market cap of 12.8K. Regarding current trading prices, RGEDF is priced at $27.17, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas TSTS's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to TSTS's ROE of +2.32%. Regarding short-term risk, RGEDF is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs IXSBF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, IXSBF has a market cap of 12.6K. Regarding current trading prices, RGEDF is priced at $27.17, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, RGEDF's ROE is +0.20%, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, RGEDF is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs VIAP Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, VIAP has a market cap of 10.3K. Regarding current trading prices, RGEDF is priced at $27.17, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas VIAP's P/E ratio is -0.05. In terms of profitability, RGEDF's ROE is +0.20%, compared to VIAP's ROE of +0.65%. Regarding short-term risk, RGEDF is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs OMHE Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, OMHE has a market cap of 9.8K. Regarding current trading prices, RGEDF is priced at $27.17, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas OMHE's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to OMHE's ROE of +0.73%. Regarding short-term risk, RGEDF is less volatile compared to OMHE. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs ALST Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, ALST has a market cap of 8.4K. Regarding current trading prices, RGEDF is priced at $27.17, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas ALST's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to ALST's ROE of +0.13%. Regarding short-term risk, RGEDF is less volatile compared to ALST. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs HBOSF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, HBOSF has a market cap of 7.8K. Regarding current trading prices, RGEDF is priced at $27.17, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, RGEDF's ROE is +0.20%, compared to HBOSF's ROE of +6.69%. Regarding short-term risk, RGEDF is more volatile compared to HBOSF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs PXYN Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, PXYN has a market cap of 6.3K. Regarding current trading prices, RGEDF is priced at $27.17, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas PXYN's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to PXYN's ROE of -0.20%. Regarding short-term risk, RGEDF is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs IYXI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, IYXI has a market cap of 5.3K. Regarding current trading prices, RGEDF is priced at $27.17, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas IYXI's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to IYXI's ROE of +1.71%. Regarding short-term risk, RGEDF is more volatile compared to IYXI. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs NEWG Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, NEWG has a market cap of 2.3K. Regarding current trading prices, RGEDF is priced at $27.17, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas NEWG's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to NEWG's ROE of +0.40%. Regarding short-term risk, RGEDF is less volatile compared to NEWG. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs FSPM Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, FSPM has a market cap of 1.3K. Regarding current trading prices, RGEDF is priced at $27.17, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas FSPM's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to FSPM's ROE of N/A. Regarding short-term risk, RGEDF is more volatile compared to FSPM. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs GRPI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, GRPI has a market cap of 1K. Regarding current trading prices, RGEDF is priced at $27.17, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas GRPI's P/E ratio is -0.02. In terms of profitability, RGEDF's ROE is +0.20%, compared to GRPI's ROE of +0.09%. Regarding short-term risk, RGEDF is more volatile compared to GRPI. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs AXMP Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, AXMP has a market cap of 409. Regarding current trading prices, RGEDF is priced at $27.17, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas AXMP's P/E ratio is 0.00. In terms of profitability, RGEDF's ROE is +0.20%, compared to AXMP's ROE of N/A. Regarding short-term risk, RGEDF is more volatile compared to AXMP. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs ACGJ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, ACGJ has a market cap of 324. Regarding current trading prices, RGEDF is priced at $27.17, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, RGEDF's ROE is +0.20%, compared to ACGJ's ROE of N/A. Regarding short-term risk, RGEDF is more volatile compared to ACGJ. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs MDVLQ Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, MDVLQ has a market cap of 161. Regarding current trading prices, RGEDF is priced at $27.17, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, RGEDF is less volatile compared to MDVLQ. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs ISHI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, ISHI has a market cap of 5. Regarding current trading prices, RGEDF is priced at $27.17, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas ISHI's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to ISHI's ROE of N/A. Regarding short-term risk, RGEDF is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs SYNI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, SYNI has a market cap of 3. Regarding current trading prices, RGEDF is priced at $27.17, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas SYNI's P/E ratio is -0.00. In terms of profitability, RGEDF's ROE is +0.20%, compared to SYNI's ROE of N/A. Regarding short-term risk, RGEDF is more volatile compared to SYNI. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs TFSHF Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, TFSHF has a market cap of 0. Regarding current trading prices, RGEDF is priced at $27.17, while TFSHF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas TFSHF's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to TFSHF's ROE of N/A. Regarding short-term risk, RGEDF is more volatile compared to TFSHF. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs MDSI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, MDSI has a market cap of 0. Regarding current trading prices, RGEDF is priced at $27.17, while MDSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas MDSI's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to MDSI's ROE of N/A. Regarding short-term risk, RGEDF is more volatile compared to MDSI. This indicates potentially higher risk in terms of short-term price fluctuations for RGEDF.
RGEDF vs GHTI Comparison
RGEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RGEDF stands at 5B. In comparison, GHTI has a market cap of 0. Regarding current trading prices, RGEDF is priced at $27.17, while GHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RGEDF currently has a P/E ratio of 7.99, whereas GHTI's P/E ratio is N/A. In terms of profitability, RGEDF's ROE is +0.20%, compared to GHTI's ROE of N/A. Regarding short-term risk, RGEDF is less volatile compared to GHTI. This indicates potentially lower risk in terms of short-term price fluctuations for RGEDF.